Decision Making for Patients With Severe Dementia Versus Normal Cognition Near the End of Life.

TitleDecision Making for Patients With Severe Dementia Versus Normal Cognition Near the End of Life.
Publication TypeJournal Article
Year of Publication2023
AuthorsNicholas, LHersch, Halpern, SD, Weir, DR, Baum, MY, Nolan, M, Gallo, J, Langa, KM
JournalInnovation in Aging
Volume7
Issue7
Paginationigad081
ISSN Number2399-5300
KeywordsAdvance care planning, cognitive impairment, family caregivers
Abstract

BACKGROUND AND OBJECTIVES: The clinical progression of severe dementia frequently leads to situations where surrogate decision makers must quickly make choices about potentially burdensome treatments that offer limited clinical benefit. We examined whether the number of decision makers and their access to advance directives were related to treatment choice for patients with severe dementia in comparison to those with normal cognition.

RESEARCH DESIGN AND METHODS: We retrospectively linked survey responses about end-of-life treatment decisions to Medicare claims for Health and Retirement Study respondents dying between 2002 and 2015 whose next-of-kin reported a need for surrogate decision making. We estimated multivariable logistic regression models to study measures of aggressive care in the last 6 months of life; in-hospital death, burdensome transfers, and burdensome treatments.

RESULTS: Compared to patients who were cognitively normal near the end of life ( = 1 198), patients with severe dementia ( = 722) were less likely to experience burdensome treatments (18% [95% confidence interval {CI} 14-21] vs 32% [95% CI 29-35]), burdensome transfers (20% [95% CI 17-24] vs 30% [95% CI 27-33]), and in-hospital death (24% [95% CI 20-28] vs 30% [95% CI 26-33]) when surrogates were involved. Rates of burdensome treatments, transfers, or in-hospital death for decedents with severe dementia did not vary with single versus multiple decision makers or when decision makers were informed by advance directives. However, among decedents with normal cognition, a single decision maker informed by an advance directive was associated with the lowest rates of burdensome treatments and in-hospital death.

DISCUSSION AND IMPLICATIONS: Surrogate decision makers made similar choices around end-of-life care for patients with severe dementia regardless of the number of decision makers and availability of advance directives. However, both advance directives and single decision makers were associated with less aggressive care for cognitively normal decedents.

DOI10.1093/geroni/igad081
Citation Key13588
PubMed ID37771715
PubMed Central IDPMC10533208
Grant ListP30 AG053760 / AG / NIA NIH HHS / United States